Hospitals are heading into a rougher policy cycle with the wrong talking points. Washington is increasingly framing healthcare as a fiscal offset, not a protected constituency, and hospitals sit squarely in the crosshairs alongside Medicaid and drug spending. That raises real exposure to site-neutral payment expansion, tighter scrutiny of tax exemption and community benefit, tougher price transparency enforcement, and state/federal action on concentrated markets. The politics are not subtle: affordability now outranks coverage as the public's chief complaint, and hospital outpatient pricing is an easy villain when CPI and commercial claims data keep showing faster growth there than almost anywhere else.

That leaves three strategic questions hospitals cannot dodge. First, affordability: not as a slogan, but as a measurable commitment tied to prices, administrative burden, and total cost of care. Blaming PBMs, Medicare, and insurers is no longer enough when consolidation, facility fees, and executive pay remain visible targets. Second, profitability: larger systems continue to outperform smaller, rural, safety-net, and independent operators, which means corporatization may be rational but is politically radioactive. Expect more debate over whether margins, tax advantages, and market power should be regulated more explicitly. Third, value-based care: after years of pilots, the scoreboard is still underwhelming. Mandatory models with downside risk are the likely next phase, but most providers still live in a fee-for-service world, so cultural transformation remains mostly PowerPoint-deep. The uncomfortable implication is that hospitals need a long-range thesis for their role in a more consumer-priced, outpatient-heavy, tech-enabled system...before regulators and employers write one for them.